These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8155273)

  • 21. [Development of new sensitizations to allergic components in birch pollen extract during specific immunotherapy].
    Modrzyński M; Zawisza E
    Przegl Lek; 2003; 60(3):130-2. PubMed ID: 14575011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring of specific IgG4 antibodies in respiratory allergy due to the pollen of Parietaria judaica. Evidence for a protective role.
    Panzani RC; Ariano R; Augeri G
    Allergol Immunopathol (Madr); 1996; 24(6):263-8. PubMed ID: 9010562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Possibilities and limitations of hyposensitization treatment in airway allergies].
    Wahn U
    Ther Umsch; 1989 Sep; 46(9):625-32. PubMed ID: 2678573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified T-cell activation pattern during specific immunotherapy (SIT) in cat-allergic patients.
    Meissner N; Kochs S; Coutelle J; Kussebi F; Baumgarten C; Løwenstein H; Kunkel G; Renz H
    Clin Exp Allergy; 1999 May; 29(5):618-25. PubMed ID: 10231321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Apropos of sublingual specific immunotherapy].
    Sabbah A
    Allerg Immunol (Paris); 1998 Apr; 30(4):97-8. PubMed ID: 9631689
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunotherapy in allergic rhinitis.
    Palma-Carlos AG; Spinola-Santos A; Ferreira MB; Santos MC; Palma-Carlos ML
    Allerg Immunol (Paris); 2001 Oct; 33(8):323-6. PubMed ID: 11763723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind placebo controlled specific immunotherapy with mixed Cupressaceae taxodiaceae pollens in respiratory allergy to Cupressus sempervirens.
    Ariano R; Panzani RC; Augeri G
    Allergol Immunopathol (Madr); 1997; 25(1):23-9. PubMed ID: 9111873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Specific (allergenic) immunotherapy: bibliographic analysis, efficacy and current practice].
    Ohman JL
    Allerg Immunol (Paris); 1994 Jan; 26(1):18, 21-4, 27-30. PubMed ID: 8166937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multicenter drug surveillance of sublingual immunotherapy in allergic patients].
    Almagro E; Asensio O; Bartolomé JM; Bosque M; de la Hoz B; Dolz I; Elorza J; Ferreiro M; García JM; Losada E
    Allergol Immunopathol (Madr); 1995; 23(4):153-9. PubMed ID: 8553989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
    Klimek L; Mewes T; Wolf H; Hansen I; Schnitker J; Mann WJ
    Otolaryngol Head Neck Surg; 2005 Oct; 133(4):538-43. PubMed ID: 16213926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
    La Grutta S; Arena A; D'Anneo WR; Gammeri E; Leonardi S; Trimarchi A; Platania D; La Rosa M
    Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation.
    Würtzen PA; Lund G; Lund K; Arvidsson M; Rak S; Ipsen H
    Clin Exp Allergy; 2008 Aug; 38(8):1290-301. PubMed ID: 18510696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of intrabronchial specific immunotherapy on certain immunologic parameters in asthmatic patients with allergic to house mites].
    Zietkowski Z
    Pol Merkur Lekarski; 1999 May; 6(35):236-8. PubMed ID: 10437389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of desensitization in the treatment of respiratory allergies].
    Vervloet D; Romanet S; Magnan A
    Rev Mal Respir; 2000 Feb; 17(1 Pt 2):287-92. PubMed ID: 10902142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of skin testing and serum-specific immunoglobulin E to predict airway reactivity to cat allergens.
    Fernández C; Cárdenas R; Martín D; Garcimartín M; Romero S; de la Cámara AG; Vives R
    Clin Exp Allergy; 2007 Mar; 37(3):391-9. PubMed ID: 17359389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy in allergic respiratory diseases.
    Vervloet D; van der Brempt X; Charpin D; Birnbaum J
    Lung; 1990; 168 Suppl():1013-24. PubMed ID: 2117102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis of respiratory allergic diseases].
    Wüthrich B
    Minerva Med; 1980 Jul; 71(29):2063-70. PubMed ID: 7402490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evidence-based appraisal of the surrogate markers of efficacy of allergen immunotherapy.
    Senna G; Calderon M; Makatsori M; Ridolo E; Passalacqua G
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):375-80. PubMed ID: 21670667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.